Tommaso Rossi MD

History 1999 Takano and Kishi identify Myopic Schisis without MH 2004 Panozzo and Mercanti use the term Myopic Traction Maculopathy 2007 Panozzo and Mercanti suggested “Retinoschisis” to be used for irreversible damage only Definition Macular retinoschisis often limited to the stapyloma with epiretinal traction, no holes and often accompanied by shallow retinal detachment Tommaso Rossi MD ® Takano M, Kishi S. Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol. 1999;128(4):472–476 Panozzo G, Mercanti A. Vitrectomy for myopic traction maculopathy. Arch Ophthalmol. 2007;125(6):767–772 Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004;122(10):1455–1460

Anatomy Isolated Foveal Thickening with Schisis (13%) Associated to Foveal Detachment (34%) Lamellar Macular Hole (20%) Epiretinal Membrane (44%) Symptoms Affected Vision Vs Non-affected Vision (Gaucher) May be Asymmptomatic for long time Visual Loss Metamorphopsia Tommaso Rossi MD ® Gaucher D, Haouchine B, Tadayoni R, Massin P, Erginay A, Benhamou N, Gaudric A. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome. Am J Ophthalmol. 2007;143:455–462. doi:

Evolution ERM presence increases the risk of visual loss 20/29 (68%) worsened visually 9/29 (31%) developed a macular hole Average follow up 31 months Tommaso Rossi MD ® Gaucher D, Haouchine B, Tadayoni R, Massin P, Erginay A, Benhamou N, Gaudric A. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome. Am J Ophthalmol. 2007;143:455–462. doi: Eye (Lond) Feb;23(2): Epub 2007 Dec 7. Factors associated with foveoschisis and foveal detachment without macular hole in high myopia. Wu PC1, Chen YJ, Chen YH, Chen CH, Shin SJ, Tsai CL, Kuo HK Prognosis (124 eyes) ERM, axial length >31mm and chorioretinal atrophy are independent risk factors for MH development

Tommaso Rossi MD ® Rare Sponaeous Resolution 207 eyes, 24 months minimum follow-up, mean FU 36 months 3.9% complete resolution 11.6% Progression of MTM Am J Ophthalmol Nov;156(5): e1. doi: /j.ajo Epub 2013 Aug 20. Natural course of myopic traction maculopathy and factors associated with progression or resolution. Shimada N1, Tanaka Y, Tokoro T, Ohno-Matsui K Prognostic Factors Better Pre-op BCVA Shorter axial lenght Absence of Foveolar Detachment Retina Jun;30(6): Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Kumagai K1, Furukawa M, Ogino N, Larson E

Lamellar/Full Thickness MH Retinal loss of Tissue Tommaso Rossi MD ® Dehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution. Hirota K, Hirakata A, Inoue M. BMC Ophthalmol Mar 29;14:39. doi: / Rare Sponaeous Resolution Vitreous Adhesion Resolution Foveolar Detachment Within the staphyloma

Observation Vs Surgery: Timing ? Optimal Surgical Timing is currently unknown Lamellar MH ERM presence Foveolar detachment Visual loss Metamorphopsia Retinal sensitivity (MP1 Microperimetry) Ratiglia R, Osnaghi S, Bindella A, Pirondini C. Posterior traction retinal detachment in highly myopic eyes: clinical features and surgical outcome as evaluated by optical coherence tomography. Retina. 2005;25(4):473–478 Futagami S, Inoue M, Hirakata A. Removal of internal limiting membrane for recurrent myopic traction maculopathy. Clin Experiment Ophthalmol. 2008;36(8):782–785. Tommaso Rossi MD ®

Vitrectomy ± ILM Peel 71 eyes ILM peeling correlated with increased BCVA ERM recurrence more often with no ILM peel Tommaso Rossi MD ® Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy. Taniuchi S, Hirakata A, Itoh Y, Hirota K, Inoue M. Retina Nov-Dec;33(10): Vitrectomy + ILM Peel 509 eyes ILM peeling correlated with increased BCVA ERM recurrence more often with no ILM peel Epiretinal membrane surgery outcomes in highly myopic eyes without traction maculopathy: long-term results of a case-control study. El Sanharawi M, Sandali O, Bonnel S, Laroche L, Monin C. Am J Ophthalmol Aug;156(2):

Vitrectomy + ILM peel 41 eyes, 6 months follow-up Mean post-op VA 20/70 (20/130 pre-op) Foveal Thickness 265 micron (558 pre-op) Eyes with foveal detachment and/or MH improved more than those with MTM alone Tommaso Rossi MD ® Vitrectomy + ILM peel 17 eyes, 6 months FU. PPV + ILM peel + C3F8 or BSS C3F8 receiving eyes improved more rapidly than BSS receiving eyes Retina Apr;31(4): Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis. Zheng B1, Chen Y, Chen Y, Zhao Z, Zhang Z, Zheng J, You Y, Wang Q, Shen L

Macular Episcleral Buckling + Vitrectomy 16 eyes Anatomical success 100% Improved vision 85% (13/16) Tommaso Rossi MD ® Dev Ophthalmol. 2014;54: doi: / Epub 2014 Aug 26. Suprachoroidal buckling. El Rayes EN1. Supra-Choroidal Buckling 24 eyes. Long-lasting hyaluronic acid 83% resolution of MH associated detachment 66% improvement of Visual Acuity Retina Jan;34(1): doi: /IAE.0b013e31828fcb77. Supra choroidal buckling in managing myopic vitreoretinal interface disorders: 1-year data. El Rayes EN1. Br J Ophthalmol Jan;98(1): doi: /bjophthalmol Epub 2013 Oct 29. Visual and anatomical outcome after macular buckling for macular hole with associated foveoschisis in highly myopic eyes. Burés-Jelstrup A1, Alkabes M, Gómez-Resa M, Rios J, Corcóstegui B, Mateo C.

Foveolar ILM NON-Peeling technique 45 eyes. 30 Foveolar NON-ILM peel; 15 total ILM peel MH developed in 16% of total peel and none Non-foveolar peel Inner/Outer Segment line recovered in 75% Non-Foveolar and 15% Total Peel Tommaso Rossi MD ® Retina Sep;34(9): Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy. Ho TC1, Yang CM, Huang JS, Yang CH, Yeh PT, Chen TC, Ho A, Chen MS Am J Ophthalmol Oct;154(4): doi: /j.ajo Epub 2012 Jul 25. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Shimada N1, Sugamoto Y, Ogawa M, Takase H, Ohno-Matsui K.

Vitreo-macular Adhesion Pharmacological Lysis (?) Ocriplasmin indication relates to “focal” adhesion (<1500 micron) Tommaso Rossi MD ® Clin Ophthalmol. 2011;5: doi: /OPTH.S Epub 2011 Aug 18. Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review. Schneider EW1, Johnson MW

Tommaso Rossi MD ®